ArticleClinical pharmacology and therapeutics2021

Benefit-Risk Assessment of Off-Label Drug Use in Children: The Bravo Framework.

Tjitske M van der Zanden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.